If your drug development timeline is on track for animal studies in the next year or two, it is important to start planning now for where and how you will conduct in vivo stage studies.

‍

To help startup and early-stage biosciences companies make the right strategic – and scientific – choice for where, and how, you’ll conduct preclinical animal studies, we’ve developed the a checklist highlighting four components to consider when planning for animal studies.